1.
Decreased butyrylcholinesterase and oxytocin levels versus increased dopamine levels in advanced Alzheimer’s patients. Ann Med Res [Internet]. 2022 Aug. 26 [cited 2025 Apr. 4];29(8):864-8. Available from: http://annalsmedres.org/index.php/aomr/article/view/4240